Big Pharma’s reputation returns to normal levels in the post-pandemic era, but the industry must connect products, innovation, and leadership with societal impact to improve trust
DENMARK, 26th January 2023 A new study published by Caliber has found that the reputation of the global pharmaceutical sector is returning to normal levels in the post-pandemic era. However, the industry must connect products, innovation, and leadership with societal impact to improve trust. According to the report, ethical behavior and corporate responsibility are critical